Published in
Springer, Investigational New Drugs, 3(34), p. 355-363, 2016
DOI: 10.1007/s10637-016-0335-x
Links
Tools
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer
Journal article published in 2016 by
Shivaani Kummar,
James L. Wade,
Amit M. Oza,
Daniel Sullivan,
Alice P. Chen,
David R. Gandara,
Jiuping Ji,
Robert J. Kinders,
Lihua Wang,
Deborah Allen,
Geraldine O’Sullivan Coyne,
Seth M. Steinberg,
James H. Doroshow
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 